Press Releases
All Releases
View Summary Enzon Treats Patients with Survivin Antagonist
Mar 19, 2009
PDF 17.6 KB Add to Briefcase
View Summary Enzon to Present at 29th Annual Cowen and Company Healthcare Conference
Mar 16, 2009
PDF 15.8 KB Add to Briefcase
View Summary Enzon Reports 2008 Results
Feb 19, 2009
PDF 36.5 KB Add to Briefcase
View Summary Enzon to Release Fourth Quarter 2008 Earnings on Thursday, February 19, 2009; Conference Call and Webcast to Follow
Feb 13, 2009
PDF 17.3 KB Add to Briefcase
View Summary Enzon Announces IND Acceptance for Its Survivin Antagonist
Feb 10, 2009
PDF 17.8 KB Add to Briefcase
View Summary Enzon Discontinues Further Development of rhMBL
Feb 10, 2009
PDF 17.4 KB Add to Briefcase
View Summary Enzon to Present at 11th Annual BIO CEO & Investor Conference
Feb 4, 2009
PDF 15.8 KB Add to Briefcase
View Summary Enzon Nominates Two New Candidates for Its Board of Directors
Jan 28, 2009
PDF 22.0 KB Add to Briefcase
View Summary Enzon Concludes Tender Offer for a Portion of Its Debt
Jan 21, 2009
PDF 17.3 KB Add to Briefcase
View Summary Enzon Pharmaceuticals Extends Tender Offer for a Portion of Its Debt
Jan 8, 2009
PDF 18.3 KB Add to Briefcase
View Summary Enzon Pharmaceuticals Commences Tender Offer for a Portion of Its Debt
Dec 8, 2008
PDF 19.4 KB Add to Briefcase
View Summary Enzon to Purchase a Portion of Its Outstanding Debt
Dec 3, 2008
PDF 19.0 KB Add to Briefcase
View Summary Enzon Discontinues Its Plan to Spin-off Its Biotechnology Business
Dec 1, 2008
PDF 17.6 KB Add to Briefcase
View Summary Enzon Reports Solid Third Quarter 2008 Results
Nov 5, 2008
PDF 26.4 KB Add to Briefcase
View Summary Enzon to Release Third Quarter 2008 Earnings on Wednesday, November 5, 2008; Conference Call and Webcast to Follow
Oct 29, 2008
PDF 16.8 KB Add to Briefcase
View Summary Enzon's HIF-1 Alpha Antagonist Shows Antitumor Activity
Oct 27, 2008
PDF 20.4 KB Add to Briefcase
View Summary Enzon Presents New Data on Its LNA Programs
Oct 20, 2008
PDF 20.6 KB Add to Briefcase
View Summary Enzon to Present Data at EORTC-NCI-AACR
Oct 16, 2008
PDF 19.1 KB Add to Briefcase
View Summary Enzon's New Oncaspar-IV(TM) Receives Orphan Drug Status in The EU
Sep 30, 2008
PDF 18.0 KB Add to Briefcase
View Summary Enzon Pharmaceuticals Announces Intention to Explore Strategic Alternatives for Specialty Pharmaceuticals Business
Aug 11, 2008
PDF 18.6 KB Add to Briefcase
Showing 81-100 of 331 Page: 1 2 3 4 5 6 7 8 9 ... 17  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase